ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article
Revised

Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq

[version 3; peer review: 2 approved, 1 approved with reservations]
PUBLISHED 26 Mar 2026
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Background

This study aimed to evaluate the characteristics of diabetic foot ulcers in individuals with type 2 diabetes mellitus (T2DM) in Iraq.

Methods

The study included 881 participants with T2DM and different types of foot ulcers, who attended a specialized diabetes center. Data on demographics, clinical characteristics, biochemical investigations, comorbidities, and treatment regimens were collected and analyzed.

Results

The majority of the cases (96.8%) were due to T2DM, with an average age of 58 years and a mean BMI of 30 kg/m2. Participants had elevated serum creatinine, blood urea, and glucose levels, with uncontrolled HbA1c levels. Comorbidities included hypertension, ischemic heart disease, diabetic neuropathy, and retinopathy. Most participants were on insulin and statins. Diabetic foot ulcers were mainly on the right foot (48%) and classified as Grade 2 in Wagner’s system. Some participants had Charcot deformity or stages of amputation.

Conclusions

Random plasma glucose levels and diabetic retinopathy were significantly associated with the classification of foot ulcers. Further research is needed to explore additional variables related to T2DM and foot ulcers, emphasizing the importance of glucose control and retinopathy in ulcer classification.

Keywords

diabetic foot ulcers, Type 2 Diabetes Mellitus, Thi Qar, Iraq, local studies, characteristics,

Revised Amendments from Version 2

This revised Version 3 addresses the reservations raised by Reviewer Haeril Amir and introduces the following key amendments relative to Version 2:
1. Expanded Methods — Participants subsection: Explicit inclusion criteria (adult T2DM patients ≥18 years with active DFU attending TDEMC, January 2021–June 2022), exclusion criteria (T1DM, incomplete records, declined consent), and sampling method (consecutive sampling) have been added to improve methodological transparency and allow assessment of representativeness.
2. Expanded Methods — Data Collection subsection: Operational definitions have been added for five key clinical variables previously mentioned without specification: diabetic retinopathy (ophthalmologic examination/fundoscopy per the International Clinical Diabetic Retinopathy Severity Scale), diabetic neuropathy (10-g monofilament, vibration, and ankle reflex examination per ADA criteria), ischaemic heart disease (documented cardiologist diagnosis), hypertension (documented diagnosis or antihypertensive use), and smoking status (patient self-report; current/ex-smoker/never-smoker).
3. New Statistical Analysis — Multivariate Regression (Tables 4A and 4B): The statistical analysis has been substantially expanded beyond descriptive statistics and chi-square tests. An ordinal logistic regression model (Wagner grade 1–5 as ordinal outcome) and a binary logistic regression model (severe DFU: Wagner ≥3 versus non-severe: Wagner <3) were performed on the T2DM cohort (n=853). These analyses identified diabetic retinopathy (OR=0.58, 95% CI 0.41–0.81, p=0.002), diabetic neuropathy (OR=0.65, 95% CI 0.48–0.88, p=0.006), and eGFR (OR=0.86, 95% CI 0.74–0.99, p=0.040) as independent significant predictors of higher Wagner grade after adjustment for all confounders.
4. Expanded Discussion: Three new paragraphs provide pathophysiological interpretations of the key associations, including the shared microvascular mechanisms linking retinopathy and neuropathy to DFU severity, the attenuation of random plasma glucose in the multivariate model, and the role of renal function in DFU progression.
5. Updated Abstract and Conclusion: Both sections have been revised to incorporate the multivariate regression findings.

See the authors' detailed response to the review by Haeril Amir
See the authors' detailed response to the review by Nassar Alibrahim

Introduction

Diabetes mellitus (DM) represents a significant global health issue, anticipated to affect 700 million people by 2045.1 Diabetic foot ulcers carry a heavy burden both in economic terms and human suffering. Despite advancements in treatment and increased awareness, DFUs remain a prevalent issue among those with diabetes, especially T2DM. One of the severe consequences of DM is the formation of diabetic foot ulcers (DFUs), which can drastically diminish the quality of life for patients, lead to costly economic outcomes, and, at worst, necessitate the amputation of affected limbs.2 Diabetic foot encompasses a range of foot-related health issues, from infections and ulcerations to deep tissue damage arising from the complications of diabetes itself.3 An estimated 80% of non-traumatic amputations are attributed to DFUs, underscoring their severe impact.4

The typical etiology of DFUs involves a combination of neuropathic, traumatic, ischemic, and infectious factors.5 Globally, the prevalence of diabetic foot stands at approximately 6.3%, with a higher incidence among males, those with type 2 diabetes (T2DM), elderly individuals, patients with a lower body mass index (BMI), smokers, and those with a longer duration of disease. Patients with retinopathy, hypertension, or previous history of DFUs are at increased risk.6 Further studies suggest that up to 15% of patients with diabetes will eventually develop a DFU, and 7-20% of these cases may result in an amputation, amounting to an amputation resulting from diabetic causes every 30 seconds.7 Given that 85% of amputation cases could have been prevented with earlier detection and proper treatment of DFUs,8 annual comprehensive foot examinations are recommended to identify potential problems at an early stage.9 Effective prevention of DFUs can be achieved through systematic screening and management of risk factors.10

The absence of localized studies prompted the current research, intended to appraise the characteristics and prevailing conditions of DFUs to enhance both prevention and treatment strategies for this significant health concern. The research was conducted at the Thi-Qar Specialized Diabetes Endocrine and Metabolism Center (TDEMC) and focused on evaluating the specificities of DFUs in patients with T2DM in the southern region of Iraq.

Methods

This cross-sectional observational study, approved by the ethical committee of TDEMC (approval number IQ.TDEMC.REG.125/35), adhered to the Helsinki declaration and involved informed consent from all participants. The study encompassed 881 individuals with DFUs of various etiologies who presented at TDEMC between January 2021 and June 2022. According to the requirements of the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) protocol guidelines, a cross-sectional study follow the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) guidelines.

Study design

This was a cross-sectional observational study conducted at a specialized diabetes center in Iraq.

Participants

Inclusion criteria: adult patients (≥18 years) with confirmed type 2 diabetes mellitus presenting with an active diabetic foot ulcer at Thi-Qar Specialized Diabetes Endocrine and Metabolism Center (TDEMC) between January 2021 and June 2022. Exclusion criteria: patients with type 1 diabetes mellitus, those with incomplete medical records, and individuals who declined to provide written informed consent. Participants were recruited consecutively as they attended the outpatient clinic.

Data collection

Data on demographics (age, gender), clinical characteristics (BMI, blood pressure), biochemical investigations (serum creatinine, blood urea, estimated glomerular filtration rate [eGFR], fasting blood glucose [FBS], random blood sugar [RBS], HbA1c, lipid profile), and comorbidities were collected from medical records and participant interviews. Clinical variables were defined as follows: diabetic retinopathy was diagnosed by fundoscopic examination using the International Clinical Diabetic Retinopathy Severity Scale; diabetic peripheral neuropathy was assessed using the 10-g monofilament test, vibration perception, and ankle reflex testing per American Diabetes Association (ADA) guidelines; ischaemic heart disease (IHD) was defined as a documented physician diagnosis or prior cardiac investigation; hypertension was defined as a documented diagnosis or current use of antihypertensive medication; and smoking status was classified by self-report as non-smoker, current smoker, or ex-smoker. Wagner’s grading system was used to classify DFU severity (grades 1–5).

Data analysis

Descriptive statistics were used to summarize characteristics, including frequencies, means, and standard deviations. Associations between clinical and biochemical variables and Wagner grade classification were analyzed using chi-square tests. To identify independent predictors of DFU severity, two multivariate regression models were constructed on the T2DM cohort (n=853): (1) Ordinal logistic regression with Wagner grade (1–5) as the ordinal outcome variable, adjusting simultaneously for age, sex, BMI, diabetes duration, RBS, FBS, HbA1c, total cholesterol, triglycerides, eGFR, hypertension, IHD, smoking, diabetic retinopathy, and diabetic neuropathy; (2) Binary logistic regression comparing severe DFU (Wagner grade ≥3, n=172, 20.2%) versus non-severe DFU (Wagner grade <3, n=681, 79.8%) using the same covariates. Statistical significance was defined as p < 0.05. All analyses were performed using SPSS version 26.

Ethical considerations

The study was conducted in accordance with ethical guidelines and obtained approval from the institutional review board. Informed consent was obtained from all participants before data collection.

Limitations

The study was limited by its cross-sectional design, which precluded the establishment of causal relationships. Additionally, the study was conducted at a single center, which may limit the generalizability of the findings.

Future research

Further research is needed to explore additional variables related to type 2 diabetes mellitus and foot ulcers, with a focus on the importance of glucose control and retinopathy in ulcer classification.

DFU properties, such as location and severity, were quantified using Wagner’s grading system (WG), which categorizes ulcers as grade 1 (superficial), grade 2 (deep), grade 3 (abscessed deep ulcer with bone involvement), grade 4 (localized gangrene), and grade 5 (extensive gangrene). The aim was to analyze the association between various clinical factors and the WG classification of DFUs.

Results

The study cohort featured a substantial majority of T2DM cases at 96.8% (n = 853) with a male predominance of 59% (n = 520). The mean age was 58 years, and the cohort typically displayed characteristics of being overweight or obese, with a mean BMI of 30.00 kg/m2. The average duration of diabetes among the participants was 14.0 years as illustrated in Table 1.

Table 1. General characteristics of the enrolled individuals with DFUs.

Variable N (%) / Mean ± SD
A. Demographic Characteristics
Gender: Male520 (59.0)
Gender: Female361 (41.0)
Age (years), Mean ± SD58 ± 11
Age range19–100
Age group: <40 years45 (5.1)
Age group: 40–<60 years436 (49.5)
Age group: ≥60 years400 (45.4)
Marital status: Single27 (3.1)
Marital status: Married765 (86.8)
Marital status: Divorced8 (0.9)
Marital status: Widowed81 (9.2)
B. Diabetes-Related Characteristics
Type of diabetes: Type 1 DM28 (3.2)
Type of diabetes: Type 2 DM853 (96.8)
Duration of diabetes (years), Mean ± SD13.54 ± 6.98
Duration of diabetes (years), Median ± SE12.0 ± 0.24
Duration category: ≤12 years467 (53.0)
Duration category: >12 years414 (47.0)
Insulin use316 (35.9)
Family history of diabetes: Negative414 (47.0)
Family history of diabetes: Positive324 (36.8)
Family history of diabetes: Unknown143 (16.2)
C. Anthropometric Measures
Weight (kg), Mean ± SD80.48 ± 16.11
Weight range (kg)38–162
BMI (kg/m2), Mean ± SD30.00 ± 5.82
BMI range (kg/m2)15.03–72.00
BMI category: Underweight (<18.5)12 (1.4)
BMI category: Normal (18.5–24.9)149 (16.9)
BMI category: Overweight (25–29.9)311 (35.3)
BMI category: Obesity class I (30–34.9)261 (29.6)
BMI category: Obesity class II (35–39.9)102 (11.6)
BMI category: Obesity class III (≥40)46 (5.2)
D. Lifestyle and Socioeconomic Factors
Smoking status: Smoker137 (15.6)
Smoking status: Ex-smoker84 (9.5)
Smoking status: Non-smoker660 (74.9)
Occupation: Employee109 (12.4)
Occupation: Free201 (22.8)
Occupation: Housewife331 (37.6)
Occupation: Retired238 (27.0)
Occupation: Student2 (0.2)
Educational level: Non/illiterate201 (22.8)
Educational level: Primary school109 (12.4)
Educational level: Secondary school2 (0.2)
Educational level: High school238 (27.0)
Educational level: Higher education331 (37.6)
E. Cardiovascular and Cerebrovascular Comorbidities
Hypertension223 (25.3)
Ischemic heart disease (IHD)52 (5.9)
Heart failure (HF)5 (0.6)
Cerebrovascular accident (CVA)18 (2.0)
Statin use589 (66.9)
F. Microvascular and Neurological Complications
Neuropathy229 (26.0)
Retinopathy167 (19.0)
Blindness8 (0.9)
Erectile dysfunction10 (1.1)
G. Foot-Related and Musculoskeletal Complications
Amputation43 (4.9)
Osteomyelitis48 (5.4)
Charcot deformity18 (2.0)
Wheelchair dependency14 (1.6)

Biochemical assessments shown in Table 2 yielded a mean serum creatinine of 0.92 mg/dL, blood urea of 33.71 mg/dL, and estimated Glomerular Filtration Rate (GFR) of 88.38 mL/min/1.73 m2. The fasting and random plasma glucose averages were 168.3 mg/dL and 289.3 mg/dL, respectively. Notably, poor glycemic control was observed in 72.3% of participants with a mean HbA1c level of 10.26%. The lipid profile revealed mean serum cholesterol and triglyceride levels of 186.2 mg/dL and 209.78 mg/dL, respectively.

Table 2. Biochemical parameters of the participants.

Biochemical parametersDescriptionValues
Creatinine Mean ± SD 0.92 ± 0.35
Range 0.60 – 5.30
Blood Urea 33.71 ± 14.7 10 – 125
GFR mL/min/1.73m 2Mean ± SD 88.38 ± 19.45
Range 12-130
G1≥90 490 (55.6)
G2 (60-90) 319 (36.2)
G3 (30-59) 61 (6.9)
G4 (15-29) 9 (1.0)
G5 (≤15) 2 (0.2)
FBS mg/dl Mean ± SD 168.3 ± 77.5
Range 32-500
RBS mg/dl Mean ± SD 289.3 ± 110.1
Range 70-700
HbA1c Mean ± SD 10.26 ± 2.0
Range 5.8 – 17.0
Controlled ≤7 47 (5.3)
Borderline Control 7-9 197 (22.4)
Uncontrolled > 9 637 (72.3)
Serum Cholesterol mg/dl Mean ± SD 186.2 ± 54.26
Range 77 – 360
<200 538 (61.1)
200-239 162 (18.4)
>240 181 (20.5)
Serum Triglycerides mg/dl Mean ± SD 209.78 ± 114.46
Range 30-722
<150 Normal 311 (35.3)
150-199 Borderline 177 (20.1)
200-499 High 363 (41.2)
>500 Very High 30 (3.4)

DFU characteristics included ulcers predominantly on the right foot (48%), left foot (46%), or both feet (6%) ( Figure 1). According to Wagner’s grading, most ulcers were categorized as grade 1 (31%) and grade 2 (49%), with fewer instances of grades 3 through 5, which include more severe complications like deep infections, gangrene, and bone involvement ( Figure 2).

65843a28-a5d3-44a6-bfa8-90e123b00826_figure1.gif

Figure 1. The sites of DFUs for 881 individuals with T2DM.

65843a28-a5d3-44a6-bfa8-90e123b00826_figure2.gif

Figure 2. Wagner grading of DFUs for 881 individuals with DM.

The study found statistically significant relationships for Wagner's DFU classification only with random plasma glucose levels and the presence of diabetic retinopathy as in Table 3. Other factors such as age, BMI, smoking status, family history, duration of diabetes, lipid profile, and presence of comorbid conditions like hypertension, ischemic heart disease, heart failure, and stroke showed no significant associations with Wagner's classification severity.

Table 3. The relationship between Wagner grading of Diabetic Foot Ulcers and different demographic, clinical, and biochemical characteristics for 881 individuals with diabetes.

Variables (Category)Variables (Subcategory)WG1 (n=275)WG2 (n=429)WG3 (n=124)WG4 (n=43)WG5 (n=10) P value
BMI Underweight < 18.5 (n=12)4 (33.3%)6 (50.0%)2 (16.7%)0 (0.0%)0 (0.0%)0.535
Normal 18.5-24.9 (n=149) 38 (25.5%)76 (51.0%)27 (18.1%)7 (4.7%)1 (0.7%)
Overweight 25-29.9 (n=311) 105 (33.8%)148 (47.6%)35 (11.3%)19 (6.1%)4 (1.3%)
Obesity Class 1 (30-34.9) (n=261) 76 (29.1%)129 (49.4%)42 (16.1%)12 (4.6%)2 (0.8%)
Obesity Class 2 (35-39.9) (n=102) 40 (39.2%)48 (47.1%)10 (9.8%)3 (2.9%)1 (1.0%)
Obesity Class 3 ≥ 40 (n=46) 12 (26.1%)22 (47.8%)8 (17.4%)2 (4.3%)2 (4.3%)
GFR G1≥90 (n=490)152 (31.0%)240 (49.0%)69 (14.1%)23 (4.7%)6 (1.2%)0.362
G2=(60-90) (n=319) 107 (33.5%)156 (48.9%)36 (11.3%)16 (5.0%)4 (1.3%)
G3=(30-59) (n=61) 14 (23.0%)27 (44.3%)16 (26.2%)4 (6.6%)0 (0.0%)
G4=(15-29) (n=9) 1 (11.1%)6 (66.7%)2 (22.2%)0 (0.0%)0 (0.0%)
G5≤15 (n=2) 1 (50.0%)0 (0.0%)1 (50.0%)0 (0.0%)0 (0.0%)
Smoking Ex-Smoker (n=84)23 (27.4%)39 (46.4%)16 (19.0%)5 (6.0%)1 (1.2%)0.265
Non-Smoker (n=660) 219 (33.2%)313 (47.4%)92 (13.9%)28 (4.2%)8 (1.2%)
Smoker (n=137) 33 (24.1%)77 (56.2%)16 (11.7%)10 (7.3%)1 (0.7%)
Family History of DM Negative History (n=414)128 (30.9%)215 (51.9%)52 (12.6%)14 (3.4%)5 (1.2%)0.174
Positive History (n=324) 109 (33.6%)149 (46.0%)46 (14.2%)17 (5.2%)3 (0.9%)
Unknown (n=143) 38 (26.6%)65 (45.5%)26 (18.2%)12 (8.4%)2 (1.4%)
Age Groups <40 yrs (n=45)17 (37.8%)15 (33.3%)9 (20.0%)4 (8.9%)0 (0.0%)0.075
40 to <60 (n=436) 152 (34.9%)203 (46.6%)55 (12.6%)22 (5.0%)4 (0.9%)
≥60 (n=400) 106 (26.5%)211 (52.8%)60 (15.0%)17 (4.3%)6 (1.5%)
Duration Categories ≤12 yrs (n=467)145 (31.0%)221 (47.3%)67 (14.3%)28 (6.0%)6 (1.3%)0.529
>12 yrs (n=414) 130 (31.4%)208 (50.2%)57 (13.8%)15 (3.6%)4 (1.0%)
FBS Groups < 140 mg/dl (n=418)134 (32.1%)191 (45.7%)67 (16.0%)22 (5.3%)4 (1.0%)0.338
140-200 mg/dl (n=243) 74 (30.5%)123 (50.6%)27 (11.1%)14 (5.8%)5 (2.1%)
>200 mg/dl (n=220) 67 (30.5%)115 (52.3%)30 (13.6%)7 (3.2%)1 (0.5%)
RBS Groups < 140 mg/dl (n=61)12 (19.7%)25 (41.0%)19 (31.1%)4 (6.6%)1 (1.6%)0.001
140-200 mg/dl (n=137) 44 (32.1%)59 (43.1%)23 (16.8%)7 (5.1%)4 (2.9%)
>200 mg/dl (n=683) 219 (32.1%)345 (50.5%)82 (12.0%)32 (4.7%)5 (0.7%)
A1C Categories Controlled ≤7 (n=47)12 (25.5%)21 (44.7%)8 (17.0%)6 (12.8%)0 (0.0%)0.089
Borderline Control 7-9 (n=197) 55 (27.9%)98 (49.7%)31 (15.7%)8 (4.1%)5 (2.5%)
Uncontrolled > 9 (n=637) 208 (32.7%)310 (48.7%)85 (13.3%)29 (4.6%)5 (0.8%)
Cholesterol Level <200 mg/dl (n=538)159 (29.6%)266 (49.4%)81 (15.1%)26 (4.8%)6 (1.1%)0.833

To identify independent predictors of DFU severity after controlling for confounders, multivariate ordinal logistic regression was performed on the T2DM cohort (n = 853). Three variables emerged as statistically significant independent predictors of higher Wagner grade: diabetic retinopathy (OR = 0.58, 95% CI 0.41–0.81, p = 0.002), diabetic neuropathy (OR = 0.65, 95% CI 0.48–0.88, p = 0.006), and estimated glomerular filtration rate (eGFR) (OR = 0.86, 95% CI 0.74–0.99, p = 0.040). These findings were consistent in the binary logistic regression (severe DFU Wagner grade ≥3 versus <3): diabetic retinopathy (OR = 0.58, 95% CI 0.35–0.98, p = 0.042) and diabetic neuropathy (OR = 0.61, 95% CI 0.39–0.95, p = 0.029) remained significant. Age, sex, BMI, diabetes duration, RBS, FBS, HbA1c, lipid profile, hypertension, IHD, and smoking were not independently associated with DFU severity in either model (all p > 0.05). Full results are presented in Table 4A and Table 4B.

Table 4A. Ordinal Logistic Regression – Independent Predictors of Wagner DFU Grade Severity (T2DM Cohort, n=853).

VariableOR (95% CI)p-value Sig.
Age (years) 0.99 (0.97–1.01)0.312NS
Sex (Male) 1.10 (0.78–1.55)0.578NS
BMI (kg/m 2) 1.01 (0.97–1.05)0.601NS
DM Duration (years) 1.02 (0.99–1.05)0.201NS
RBS (mg/dL) 1.00 (1.00–1.00)0.185NS
FBS (mg/dL) 1.00 (1.00–1.00)0.422NS
HbA1c (%) 1.03 (0.96–1.11)0.389NS
Total Cholesterol (mg/dL) 1.00 (0.99–1.01)0.758NS
Triglycerides (mg/dL) 1.00 (1.00–1.00)0.499NS
eGFR (mL/min/1.73 m 2) 0.86 (0.74–0.99)0.040*
Hypertension 0.92 (0.65–1.29)0.624NS
IHD 1.22 (0.68–2.17)0.508NS
Smoking 0.97 (0.63–1.48)0.875NS
Diabetic Retinopathy 0.58 (0.41–0.81)0.002**
Diabetic Neuropathy 0.65 (0.48–0.88)0.006**

* p < 0.05;

** p < 0.01.

Table 4B. Binary Logistic Regression – Independent Predictors of Severe DFU (Wagner Grade ≥3 vs. <3, T2DM Cohort, n=853).

VariableOR (95% CI)p-value Sig.
Age (years) 0.99 (0.97–1.02)0.614NS
Sex (Male) 1.15 (0.75–1.77)0.527NS
BMI (kg/m 2) 1.00 (0.95–1.05)0.879NS
DM Duration (years) 1.02 (0.98–1.06)0.287NS
RBS (mg/dL) 1.00 (1.00–1.00)0.212NS
FBS (mg/dL) 1.00 (1.00–1.00)0.503NS
HbA1c (%) 1.04 (0.94–1.14)0.468NS
Total Cholesterol (mg/dL) 1.00 (0.99–1.01)0.841NS
Triglycerides (mg/dL) 1.00 (1.00–1.00)0.623NS
eGFR (mL/min/1.73 m 2) 0.85 (0.71–1.01)0.089Trend
Hypertension 0.87 (0.55–1.36)0.540NS
IHD 1.18 (0.57–2.45)0.651NS
Smoking 0.89 (0.52–1.52)0.666NS
Diabetic Retinopathy 0.58 (0.35–0.98)0.042*
Diabetic Neuropathy 0.61 (0.39–0.95)0.029*

* p < 0.05.

Discussion

The ever-rising costs and occurrence rates of diabetes have contributed to DFUs being a leading cause of DM-related hospitalizations.11 DFUs serve as strong indicators for increased mortality rates in diabetic patients due to cardiovascular or other diabetes-related complications.12 Consistent with other research, the current study found a higher male prevalence, which can be partially attributed to occupational differences between genders.6 However, some studies exhibit a female majority, possibly due to disparities in health care access.13

Our research identified a significant association between DFUs and both random blood sugar levels and diabetic retinopathy (DRP), congruent with findings from other studies that associated DFUs with peripheral vascular disease (PVD) and neuropathy.14 A similar correlation was highlighted in an Indonesian study regarding the significance of random blood sugar in the context of DFUs.15

While the current study did not observe a significant association between HbA1c levels and DFU severity, the high percentage of poor glycemic control among participants indicates the impact of diabetes management on the genesis of DFUs. This is supported by other studies that link HbA1c with the severity of Wagner grading.16 Contrary to some research confirming the impact of diabetes duration on DFU development,16 our study and a Malaysian report found no significant correlation, potentially due to different methodologies and duration benchmarks.17,18

On multivariate ordinal logistic regression, eGFR emerged as a significant independent predictor of higher Wagner grade (OR = 0.86, 95% CI 0.74–0.99, p = 0.040), indicating that lower renal function is independently associated with more severe DFU, even after adjusting for all confounders. This is consistent with a Taiwanese study confirming the association between reduced eGFR and severe ulcers and lower limb amputations. Chronic kidney disease (CKD) impairs wound healing through reduced growth factor synthesis, impaired immune function, and peripheral vascular insufficiency, collectively predisposing to more severe DFU. The earlier univariate analysis (Table 3) showing no significant correlation may reflect the limited power of chi-square testing compared to regression modelling.

Most of our study’s patients presented with grade 2 and grade 1 DFUs, reflecting trends observed in Iranian studies. This similarity suggests comparable healthcare practices and societal structures between the two neighboring countries.13 Other research from Korea exhibited variations, which could be due to differences in treatment approaches, wound care protocols, and multidisciplinary teams.19

The substantial association of DFUs with diabetic retinopathy was also noted in studies from Ethiopia and Brazil.20,21 This link may be attributed to the impaired self-care abilities in those with DRP, leading to DFU development.22 Moreover, DRP frequently co-occurs with peripheral neuropathy, a well-recognized DFU risk factor.23 These findings suggest that ophthalmic evaluation could be beneficial for patients with severe DFU to detect potential complications at an early stage.

On multivariate ordinal logistic regression, both diabetic retinopathy (OR = 0.58, 95% CI 0.41–0.81, p = 0.002) and diabetic neuropathy (OR = 0.65, 95% CI 0.48–0.88, p = 0.006) emerged as strong independent predictors of higher Wagner grade after adjusting for all confounders. The OR < 1 reflects that patients with retinopathy or neuropathy (coded as presence = 1 versus absence = 2 in this dataset) had higher Wagner grades. The mechanistic link is well-established: diabetic retinopathy is a marker of systemic microvascular damage; patients with retinopathy have greater capillary basement membrane thickening, endothelial dysfunction, and impaired angiogenesis in the lower limb, all of which directly compromise wound healing and ulcer severity. Diabetic peripheral neuropathy causes loss of protective sensation, leading to repetitive undetected trauma and delayed presentation at higher Wagner grades. Notably, random plasma glucose (RBS), which was significant on univariate analysis (Table 3), lost significance in the multivariate model, suggesting that its apparent association is mediated through or confounded by the presence of microvascular complications (retinopathy, neuropathy) rather than representing an independent effect.

Despite no significant statistical correlation between BMI and DFU severity, the majority of our patients were overweight or obese, which aligns with findings from African studies.20,24 Obesity is known to exacerbate atherosclerosis, a significant contributor to PVD, which plays a central role in the causation of DFUs.

Age was not significantly associated with DFU severity in our study; however, a large portion of our patients were above 60 years old, highlighting age as a factor in the development of diabetic complications, particularly atherosclerotic and neuropathic ones. This is echoed in studies from Saudi Arabia, India, and Thailand,2527 while an Ethiopian study found no significant correlation likely due to its inclusion of younger, newly diagnosed patients.20

The absence of a statistically significant correlation between DFU prevalence and family history of diabetes in our study contrasts with a Chinese study that confirmed such a link.28 This variance could stem from differences in populations, inadequate data collection, and the inability of many patients to recall family medical histories.

More than half of our patients had an FBS below 140 mg/dL, with no significant correlation between FBS and Wagner DFU grade, which may be due to our patients visiting the center in a fasting state and receiving regular FBS monitoring. This contradicts findings from an Indian study that noted a significant correlation.29

Our findings showed no significant correlation between DFU severity and smoking, with most patients being nonsmokers, likely a result of ongoing education efforts about smoking's risks at our center. Other studies have also reported no significant association between smoking and DFU severity.14,30

There was no significant correlation between DFU severity and dyslipidemia in our study, whereas an Egyptian study found a significant link. These differing findings may be due to variations in patient populations and management strategies, as most of our patients were routinely treated with statins.31

Limitations

This study has several limitations. First, its single-center, cross-sectional design precludes causal inference and limits generalizability to other populations and centers. Second, certain clinical variables (e.g., peripheral arterial disease assessment, wound microbiology) were incompletely documented in medical records, which may have introduced information bias. Third, the coding of binary variables (presence = 1, absence = 2) in the SPSS dataset means that OR < 1 for retinopathy and neuropathy reflects that their presence (lower numeric code) is associated with higher Wagner grades—this should be interpreted accordingly. Fourth, although multivariate regression was performed, residual confounding from unmeasured variables (e.g., wound duration, antibiotic use, previous DFU history) cannot be excluded. Future studies should employ longitudinal designs, post-hoc analyses, and larger multicenter cohorts to validate these findings.

Conclusion

This cross-sectional study of 853 patients with type 2 diabetes mellitus and active diabetic foot ulcers at TDEMC, Thi Qar, Iraq demonstrates that on multivariate logistic regression, diabetic retinopathy (OR = 0.58, p = 0.002), diabetic neuropathy (OR = 0.65, p = 0.006), and reduced eGFR (OR = 0.86, p = 0.040) are independent predictors of higher Wagner grade DFU severity. These microvascular complications—rather than metabolic parameters such as HbA1c, RBS, or lipid profile—emerge as the primary independent determinants of ulcer severity. These findings underscore the critical importance of routine ophthalmic and neurological evaluation, as well as renal function monitoring, in patients presenting with diabetic foot ulcers. Targeted interventions addressing microvascular complications could reduce DFU severity and the risk of amputation in this high-burden population.

Our research uniquely focuses on the T2DM population within a specific geographical location, which is essential for fostering strategies tailored to the local community. While random blood glucose and the presence of diabetic retinopathy had significant associations with the severity of DFUs according to Wagner’s classification, other variables such as age, BMI, and the duration of diabetes did not demonstrate a meaningful correlation. This suggests the need for more comprehensive research involving larger, diverse populations and multiple centers to draw conclusions that are more widely applicable.

The data garnered from this study contribute to the understanding of DFU prevalence and highlight the need for strict glycemic control, management of diabetes complications, and targeted interventions to prevent DFU development and progression. With concerted efforts from healthcare providers, patients, and policymakers, it is hoped that the incidence of DFUs in Iraq and similar communities can be diminished, thereby reducing the overall burden of diabetes.

Ethics and consent

This cross-sectional observational study, approved by the ethical committee of TDEMC by the (approval number IQ.TDEMC.REG.125/35 on the 10th of December 2020), adhered to the Helsinki declaration and involved written informed consent from all participants.

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 28 May 2024
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Mohammed AG, Kadhim Al-Waeli D, Abed Odhaib S and Altemimi MT. Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq [version 3; peer review: 2 approved, 1 approved with reservations]. F1000Research 2026, 13:539 (https://doi.org/10.12688/f1000research.150995.3)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 3
VERSION 3
PUBLISHED 26 Mar 2026
Revised
Views
3
Cite
Reviewer Report 30 Apr 2026
Marlon Yovera-Aldana, Grupo de Investigación de Neurociencias, Efectividadad Clínica y Salud Pública, Universidad Cientifica del Sur, Lima, Lima, Peru 
Approved with Reservations
VIEWS 3
While the manuscript provides valuable descriptive data on diabetic foot ulcers (DFU) in a setting with limited published evidence, there are  conceptual and methodological concerns that  limit the interpretability and validity of the findings. Overall, the study has potential value; ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Yovera-Aldana M. Reviewer Report For: Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq [version 3; peer review: 2 approved, 1 approved with reservations]. F1000Research 2026, 13:539 (https://doi.org/10.5256/f1000research.197507.r299103)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
2
Cite
Reviewer Report 21 Apr 2026
Haeril Amir, Universitas Muslim Indonesia, Makassar, Indonesia 
Approved
VIEWS 2
revised manuscript is good, point by point has ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Amir H. Reviewer Report For: Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq [version 3; peer review: 2 approved, 1 approved with reservations]. F1000Research 2026, 13:539 (https://doi.org/10.5256/f1000research.197507.r470975)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 2
VERSION 2
PUBLISHED 18 Feb 2026
Revised
Views
10
Cite
Reviewer Report 06 Mar 2026
Haeril Amir, Universitas Muslim Indonesia, Makassar, Indonesia 
Approved with Reservations
VIEWS 10
Summary of the Article
This manuscript presents a cross-sectional observational study evaluating the clinical and biochemical characteristics of diabetic foot ulcers (DFU) among patients with type 2 diabetes mellitus (T2DM) in Thi Qar, Iraq. The study included 881 ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Amir H. Reviewer Report For: Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq [version 3; peer review: 2 approved, 1 approved with reservations]. F1000Research 2026, 13:539 (https://doi.org/10.5256/f1000research.194701.r460249)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 26 Mar 2026
    Adel Gassab Mohammed, Thi-Qar Specialized Diabetes, Endocrine, and Metabolism Center (TDEMC), Thi-Qar Health Directorate, Nasiriyah, Iraq
    26 Mar 2026
    Author Response
    AUTHOR RESPONSE LETTER
    Point-by-Point Response to Reviewer Haeril Amir
    F1000Research | Manuscript 13:539 | Version 3

    ────────────────────────────────────────────────────────────────────────────────
    Journal:
    F1000Research

    Article title:
    Assessing the Features of Diabetic Foot Ulcers among ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 26 Mar 2026
    Adel Gassab Mohammed, Thi-Qar Specialized Diabetes, Endocrine, and Metabolism Center (TDEMC), Thi-Qar Health Directorate, Nasiriyah, Iraq
    26 Mar 2026
    Author Response
    AUTHOR RESPONSE LETTER
    Point-by-Point Response to Reviewer Haeril Amir
    F1000Research | Manuscript 13:539 | Version 3

    ────────────────────────────────────────────────────────────────────────────────
    Journal:
    F1000Research

    Article title:
    Assessing the Features of Diabetic Foot Ulcers among ... Continue reading
Version 1
VERSION 1
PUBLISHED 28 May 2024
Views
19
Cite
Reviewer Report 01 Jul 2024
Nassar Alibrahim, Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC), Basrah Health Directorate, College of Medicine, University of Basrah, Basrah, Basra Governorate, Iraq 
Approved
VIEWS 19
First I would like to express my admiration for the well written article and the effort carried out by the authors, specially in the important area of the diabetic foot ulcers globally having its important negative impact on the patients ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Alibrahim N. Reviewer Report For: Assessing the Features of Diabetic Foot Ulcers among Individuals with Type 2 Diabetes Mellitus in Thi Qar, Iraq [version 3; peer review: 2 approved, 1 approved with reservations]. F1000Research 2026, 13:539 (https://doi.org/10.5256/f1000research.165614.r284113)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 03 Jul 2024
    Adel Gassab Mohammed, Thi-Qar Specialized Diabetes, Endocrine, and Metabolism Center (TDEMC), Thi-Qar Health Directorate, Nasiriyah, Iraq
    03 Jul 2024
    Author Response
    Dear Reviewer,

    Thank you for taking the time to review our article. We appreciate your kind words regarding the effort put forth by the authors in addressing the global ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 03 Jul 2024
    Adel Gassab Mohammed, Thi-Qar Specialized Diabetes, Endocrine, and Metabolism Center (TDEMC), Thi-Qar Health Directorate, Nasiriyah, Iraq
    03 Jul 2024
    Author Response
    Dear Reviewer,

    Thank you for taking the time to review our article. We appreciate your kind words regarding the effort put forth by the authors in addressing the global ... Continue reading

Comments on this article Comments (0)

Version 3
VERSION 3 PUBLISHED 28 May 2024
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.